Verve Therapeutics, Inc.
VERVDelisted Jul 25, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001840574
Verve Therapeutics, Inc. was delisted on Jul 25, 2025; its insiders filed their last Form 4 on Jul 28, 2025; 176 institutions reported holding it in 13F filings for Q2 2025, worth $819.4M in total; no superinvestor held it.
13F holders, Q2 2023
Institutional positions in Verve Therapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 121
- −4 vs. Q1 2023
- Shares held
- 61.9M
- −1.39M (−2.2%) vs. Q1 2023
- Total value
- $1.16B
- +$248.5M (+27.3%) vs. Q1 2023
- New holders
- 15
- 49 more added
- Sold out
- 19
- 37 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VERV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 3 | $0 |
| Q1 2026 | 3 | $0 |
| Q4 2025 | 4 | $344.0K |
| Q3 2025 | 9 | $1.53M |
| Q2 2025 | 176 | $819.4M |
| Q1 2025 | 191 | $369.3M |
| Q4 2024 | 166 | $443.9M |
| Q3 2024 | 174 | $364.6M |
| Q2 2024 | 167 | $371.8M |
| Q1 2024 | 163 | $1.08B |
| Q4 2023 | 157 | $1.04B |
| Q3 2023 | 134 | $847.0M |
| Q2 2023 | 121 | $1.16B |
| Q1 2023 | 125 | $911.8M |
| Q4 2022 | 123 | $1.21B |
| Q3 2022 | 124 | $2.08B |
| Q2 2022 | 101 | $695.8M |
| Q1 2022 | 92 | $1.06B |
| Q4 2021 | 96 | $1.66B |
| Q3 2021 | 73 | $1.81B |
| Q2 2021 | 69 | $2.25B |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Verve Therapeutics, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BVF Inc | 650,000 | $12.2M | 0.34% | 00.0% | Unchanged |
| Citadel Advisors LLC | 696,040 | $13.1M | 0.01% | +271,178+63.8% | Added |
| MPM Oncology Impact Management LP | 857,940 | $16.1M | 3.24% | +54,439+6.8% | Added |
| Avidity Partners Management LP | 878,600 | $16.5M | 0.58% | −473,100−35.0% | Reduced |
| Geode Capital Management, LLC | 956,727 | $17.9M | 0.00% | +70,956+8.0% | Added |
| Wellington Management Group LLP | 976,128 | $18.3M | 0.00% | +42,961+4.6% | Added |
| Redmile Group, LLC | 1,061,960 | $19.9M | 0.76% | −58,719−5.2% | Reduced |
| Baker Bros. Advisors LP | 1,416,530 | $26.6M | 0.15% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 1,838,986 | $34.5M | 0.00% | −69,378−3.6% | Reduced |
| ARCH Venture Management, LLC | 2,008,809 | $37.7M | 23.26% | 00.0% | Unchanged |
| T. Rowe Price Investment Management, Inc. | 2,101,361 | $39.4M | 0.03% | +95,234+4.7% | Added |
| Nikko Asset Management Americas, Inc. | 2,185,857 | $40.9M | 0.43% | +587,863+36.8% | Added |
| Sumitomo Mitsui Trust Holdings, Inc. | 2,185,857 | $41.0M | 0.03% | +587,863+36.8% | Added |
| Casdin Capital, LLC | 2,360,571 | $44.3M | 3.87% | +240,000+11.3% | Added |
| Federated Hermes, Inc. | 2,402,640 | $45.0M | 0.11% | 00.0% | Unchanged |
| State Street Corp | 3,063,032 | $57.4M | 0.00% | −286,745−8.6% | Reduced |
| BlackRock Inc. | 3,846,703 | $72.1M | 0.00% | +300,218+8.5% | Added |
| Vanguard Group Inc | 4,091,215 | $76.7M | 0.00% | +212,365+5.5% | Added |
| ARK Investment Management LLCSuperinvestorARK Invest | 5,150,851 | $96.6M | 0.64% | +668,760+14.9% | Added |
| FMR LLC | 6,046,380 | $113.4M | 0.01% | −780,437−11.4% | Reduced |
| Alphabet Inc. | 10,549,086 | $197.8M | 10.63% | 00.0% | Unchanged |
| Rock Springs Capital Management LP | 0 | $0 | 0.00% | −558,837−100.0% | Sold out |
| Hood River Capital Management LLC | 0 | $0 | 0.00% | −344,776−100.0% | Sold out |
| Twinbeech Capital LP | 0 | $0 | 0.00% | −143,520−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −141,756−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −54,284−100.0% | Sold out |
| Capital Fund Management S.A. | 0 | $0 | 0.00% | −37,093−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −28,679−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −26,720−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −23,252−100.0% | Sold out |
| Candriam Luxembourg S.C.A. | 0 | $0 | 0.00% | −25,547−100.0% | Sold out |
| Point72 Middle East FZE | 0 | $0 | 0.00% | −16,498−100.0% | Sold out |
| Martingale Asset Management L P | 0 | $0 | 0.00% | −16,273−100.0% | Sold out |
| Vontobel Holding Ltd. | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −3,100−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Amundi | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Red Tortoise LLC | 0 | $0 | 0.00% | −94−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| Steward Financial Group LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |